AIMCA
ENTA icon

Alberta Investment Management Corp (AIMCo)’s Enanta Pharmaceuticals ENTA Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,200
Closed -$1.28M – 928
2019
Q2 		$1.28M Buy
+15,200
New +$1.37M 0.01% 584
2017
Q1 		– Sell
-6,400
Closed -$214K – 825
2016
Q4 		$214K Sell
6,400
-11,300
-64% -$324K ﹤0.01% 681
2016
Q3 		$471K Buy
+17,700
New +$411K ﹤0.01% 617

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ENTA Position: Q3 2019 in Review

Alberta Investment Management Corp (AIMCo) sold out of Enanta Pharmaceuticals (ENTA) in Q3 2019, closing a stake of 15,200 shares — an estimated $1.28M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ENTA in Q3 2016 and held it in 3 quarters. The position peaked at $1.28M in Q2 2019. 176 funds tracked by Wall St. Rank hold ENTA as of Q3 2019.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Enanta Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 15,200 Enanta Pharmaceuticals shares in Q3 2019, an estimated $1.28M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Enanta Pharmaceuticals in Q3 2016 and held it in 3 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Enanta Pharmaceuticals position peaked at $1.28M in Q2 2019.
  • 176 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2019.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2019, filed 23 Oct 2019.